Name: Albemarle Corp. (NYSE:ALB) | Income Statement (Quarterly)
Creator: Stock Analysis on Net

Income Statement
Quarterly Data

The income statement presents information on the financial results of a company business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.

Download chart

Albemarle Corp., consolidated income statement (quarterly data)

US$ in thousands

3 months ended:	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018
Net sales	2,580,252)	2,620,978)	2,091,805)	1,479,593)	1,127,728)	894,204)	830,566)	773,896)	829,291)	879,147)	746,868)	764,049)	738,845)	992,564)	879,747)	885,052)	832,064)	921,699)	777,748)	853,874)	821,629)
Cost of goods sold	(1,303,712)	(1,619,659)	(1,047,991)	(899,169)	(678,698)	(657,610)	(581,293)	(525,479)	(565,604)	(613,727)	(492,812)	(530,690)	(496,827)	(654,053)	(569,880)	(559,138)	(548,578)	(601,315)	(497,211)	(542,518)	(516,650)
Gross profit	1,276,540)	1,001,319)	1,043,814)	580,424)	449,030)	236,594)	249,273)	248,417)	263,687)	265,420)	254,056)	233,359)	242,018)	338,511)	309,867)	325,914)	283,486)	320,384)	280,537)	311,356)	304,979)
Selling, general and administrative expenses	(154,306)	(148,156)	(134,479)	(128,942)	(112,568)	(123,302)	(103,477)	(121,516)	(93,187)	(124,909)	(96,092)	(106,949)	(101,877)	(185,163)	(108,135)	(126,715)	(113,355)	(120,916)	(100,167)	(123,637)	(101,370)
Research and development expenses	(20,471)	(20,154)	(18,358)	(17,386)	(16,083)	(12,125)	(13,289)	(13,976)	(14,636)	(15,375)	(13,532)	(14,210)	(16,097)	(14,263)	(15,585)	(13,462)	(14,977)	(16,384)	(16,610)	(16,074)	(20,986)
Gain (loss) on sale of interest in properties	—)	—)	—)	—)	(8,400)	(132,453)	(984)	429,408)	—)	—)	—)	—)	—)	—)	—)	—)	—)	(8,277)	—)	218,705)	—)
Operating profit	1,101,763)	833,009)	890,977)	434,096)	311,979)	(31,286)	131,523)	542,333)	155,864)	125,136)	144,432)	112,200)	124,044)	139,085)	186,147)	185,737)	155,154)	174,807)	163,760)	390,350)	182,623)
Interest and financing expenses	(26,777)	(24,039)	(29,691)	(41,409)	(27,834)	(5,306)	(5,136)	(7,152)	(43,882)	(19,152)	(19,227)	(17,852)	(16,885)	(22,400)	(11,108)	(11,601)	(12,586)	(12,571)	(12,988)	(13,308)	(13,538)
Other income (expenses), net	82,492)	54,119)	7,974)	8,767)	15,496)	28,530)	(643,196)	14)	11,312)	(57,557)	(3,661)	(6,273)	8,314)	(38,388)	(11,316)	(7,065)	11,291)	(32,528)	3,793)	(5,223)	(30,476)
Income (loss) before income taxes and equity in net income of unconsolidated investments	1,157,478)	863,089)	869,260)	401,454)	299,641)	(8,062)	(516,809)	535,195)	123,294)	48,427)	121,544)	88,075)	115,473)	78,297)	163,723)	167,071)	153,859)	129,708)	154,565)	371,819)	138,609)
Income tax (expense) benefit	(276,963)	(24,102)	(196,938)	(89,018)	(80,530)	(15,024)	114,670)	(106,985)	(22,107)	10,101)	(30,653)	(15,431)	(18,442)	5,105)	(25,341)	(30,411)	(37,514)	(11,196)	(33,167)	(80,102)	(20,361)
Income (loss) before equity in net income of unconsolidated investments	880,515)	838,987)	672,322)	312,436)	219,111)	(23,086)	(402,139)	428,210)	101,187)	58,528)	90,891)	72,644)	97,031)	83,402)	138,382)	136,660)	116,345)	118,512)	121,398)	291,717)	118,248)
Equity in net income of unconsolidated investments, net of tax	396,188)	322,799)	258,884)	128,156)	62,436)	33,555)	27,706)	17,998)	16,511)	43,649)	26,154)	31,114)	26,604)	22,841)	33,236)	38,310)	35,181)	27,537)	22,081)	18,969)	20,677)
Net income (loss)	1,276,703)	1,161,786)	931,206)	440,592)	281,547)	10,469)	(374,433)	446,208)	117,698)	102,177)	117,045)	103,758)	123,635)	106,243)	171,618)	174,970)	151,526)	146,049)	143,479)	310,686)	138,925)
Net income attributable to noncontrolling interests	(38,123)	(29,341)	(33,991)	(33,819)	(28,164)	(14,293)	(18,348)	(21,608)	(22,021)	(17,542)	(18,744)	(18,134)	(16,431)	(15,852)	(16,548)	(20,772)	(17,957)	(16,453)	(13,734)	(8,225)	(7,165)
Net income (loss) attributable to Albemarle Corporation	1,238,580)	1,132,445)	897,215)	406,773)	253,383)	(3,824)	(392,781)	424,600)	95,677)	84,635)	98,301)	85,624)	107,204)	90,391)	155,070)	154,198)	133,569)	129,596)	129,745)	302,461)	131,760)

A profound shift in financial performance is observed between the 2018-2021 period and the 2022-2023 period. While the earlier years were characterized by relative stability in revenue and profitability, the latter period shows exponential growth in both top-line sales and bottom-line net income.

Revenue and Gross Profit Trends: Net sales remained largely consistent from March 2018 through December 2021, typically fluctuating between $738 million and $992 million per quarter. A sharp upward trajectory began in March 2022, with quarterly sales increasing from $1.13 billion to a peak of $2.62 billion by December 2022. This expansion is accompanied by a significant increase in gross profit, which rose from a historical quarterly average of approximately $280 million to $1.27 billion by March 2023, indicating expanded margins and strong pricing power during the 2022-2023 window.
Operating Expense Analysis: Selling, general and administrative (SG&A) expenses and research and development (R&D) costs remained remarkably stable despite the massive surge in revenue. SG&A expenses hovered around $100 million to $130 million for several years, only increasing slightly to $154 million by March 2023. R&D spending followed a similar pattern of stability, staying within the $12 million to $20 million range. This divergence between rapidly growing revenue and stagnant operating expenses suggests significant operating leverage.
Operating Profit and Volatility: Operating profit showed stability until late 2021, where a contraction occurred, resulting in an operating loss of $31.3 million in December 2021. This was largely influenced by a loss on the sale of interest in properties. However, a recovery followed immediately, with operating profit climbing to $1.10 billion by March 2023, reflecting the impact of higher sales volumes and controlled cost structures.
Net Income and Non-Operating Drivers: Net income attributable to the corporation experienced extreme volatility in 2021, including a spike to $424.6 million in June 2021 and a sharp decline to a loss of $392.8 million in September 2021. Following this volatility, net income entered a phase of aggressive growth, rising from $253.4 million in March 2022 to $1.24 billion in March 2023. A critical driver of this growth is the equity in net income of unconsolidated investments, which increased from quarterly contributions of approximately $20 million in 2018 to $396.2 million by March 2023, significantly augmenting the total net income.

AI Ask an analyst for more

My previous chats

Add tokens

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?

Albemarle Corp. (NYSE:ALB)

Income StatementQuarterly Data

Income Statement
Quarterly Data